Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Report 2026

Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Overview

• Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial market size has reached to $2.01 billion in 2025 • Expected to grow to $3.77 billion in 2030 at a compound annual growth rate (CAGR) of 13.3% • Growth Driver: Surge In Global Vaccination Participation Driving The Growth Of The Market Due To Easier Distribution And Wider Accessibility • Market Trend: Companies Focus On Innovation To Enhance Manufacturing Efficiency And Global Accessibility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

A temperature-stable messenger ribonucleic acid (mRNA) vial is a specially designed container that maintains the integrity and effectiveness of mRNA formulations without requiring ultra-cold storage. It uses advanced stabilization technologies to protect the sensitive mRNA molecules from degradation at higher temperatures, allowing for easier handling, wider distribution, and more reliable use of mRNA-based products. The main product types of temperature-stable messenger ribonucleic acid (mRNA) vials include lipid nanoparticle formulations, polymer-based formulations, lyophilized messenger ribonucleic acid (mRNA) vials, and others. Lipid nanoparticle formulations are delivery systems that encapsulate and protect messenger RNA molecules for efficient cellular uptake. It is distributed through direct sales, distributors, online sales, and others and is applied for vaccines, therapeutics, research, and others. It is used by several end users, including hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and others.

What Is The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Growth Forecast?

The temperature-stable messenger ribonucleic acid (mrna) vial market size is expected to see rapid growth in the next few years. It will grow to $3.77 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing demand for next-generation mrna therapeutics, rising focus on global vaccine accessibility, expansion of decentralized healthcare delivery, growing investments in temperature-stable biologics, increased regulatory approvals for mrna-based products. Major trends in the forecast period include increasing development of thermostable mrna formulations, rising adoption of lyophilized mrna vials, growing demand for cold-chain independent storage solutions, expansion of global mrna distribution programs, enhanced focus on packaging integrity and stability.

What Is The Driver Of The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

The increasing participation in global vaccination is expected to propel the growth of the temperature-stable messenger ribonucleic acid (mRNA) vial market going forward. A vaccine is a substance designed to trigger the body’s immune response, helping it build protection against a particular disease. The rise in global vaccine participation is driven by international collaboration, as coordinated efforts between countries ensure wider access and equitable distribution of vaccines. Temperature-stable mRNA vials support global vaccination by enabling easier storage, transportation, and distribution across diverse regions without reliance on complex cold chain systems, thereby ensuring wider accessibility and sustained immunization coverage worldwide. For instance, in October 2025, according to Gavi, a US-based international organization that provides vaccines to children in developing countries, DTP3 vaccine coverage in Gavi-supported lower-income countries increased to 82%, up from 80% in 2023, nearing pre-pandemic levels. Therefore, the increasing participation in global vaccination is driving the growth of the temperature-stable messenger ribonucleic acid (mRNA) vial market.

Key Players In The Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market

Major companies operating in the temperature-stable messenger ribonucleic acid (mrna) vial market are Arcturus Therapeutics Holdings Inc., CureVac AG, Sanofi S.A., Lonza Group AG, Gerresheimer AG, Stevanato Group, Schott AG, CSafe Global, Gennova Biopharmaceuticals Ltd., TTP Group, Peli BioThermal LLC, SiO2 Materials Science, Shijiazhuang Xinfuda Medical Packaging, Vaxess Technologies, Ethris, Lyophilization Techniques, 20Med Therapeutics BV, EnsiliTech, HDT Bio Corp., Emervax.

Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Trends and Insights

Major companies operating in the temperature-stable messenger ribonucleic acid (mRNA) vial market are focusing on developing innovative approaches, such as technology transfer models, to enhance manufacturing efficiency, expand global production capacity, and improve accessibility of vaccines in low- and middle-income countries. Technology transfer models refer to processes for sharing knowledge, skills, and manufacturing techniques from one organization to another to enable local production and wider distribution. For instance, in January 2024, SCHOTT Pharma, a Germany-based pharmaceutical packaging company, launched the EVERIC freeze vials. EVERIC freeze vials withstand temperatures as low as -80°C, making them suitable for vaccines and drugs such as mRNA and gene therapy treatments used for infectious diseases, cancer, and central nervous system disorders. Their strength-optimized design reduces the risk of breakage, preventing loss of life-saving medications and costly downtimes.

What Are Latest Mergers And Acquisitions In The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

In February 2023, 20med equipment solutions private limited, a Netherlands-based company provides digital transformation services and a B2B marketplace for healthcare businesses, partnered with Coalition for Epidemic Preparedness Innovations (CEPI) to develop RNA and DNA vaccines and therapeutics. Through this partnership, CEPI and 20Med seek to advance bio-responsive nanoparticle technology to eliminate the need for frozen storage of mRNA vaccines and improve global vaccine accessibility. Coalition for Epidemic Preparedness Innovations (CEPI) a Norway-based supports innovations like temperature-stable mRNA vials to improve vaccine storage, distribution, and accessibility worldwide.

What Defines the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?

The temperature-stable messenger ribonucleic acid (mRNA) vial consists of sales of stoppers, seals, caps, labels, and packaging materials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Report 2026?

The temperature-stable messenger ribonucleic acid (mrna) vial market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the temperature-stable messenger ribonucleic acid (mrna) vial industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.